The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
"It's alive" - RNS
I can't imagine a situation in which major shareholders would allow AVO to fail for want of a few million.
Harley Street building, fully converted to accomodate LIGHT, must be a big draw to any proton therapy operator wishing to adopt this disruptive technology. Mrs. RenHua Zhang of Liquid Harmony ltd gives her correspondence address as 143 Harley Street at companies house?
It’s no secret the company was seeking a partner so if one has been found to fund the business then happy days.
Share dilution will happen.
The technology AVO have is priceless, existing shareholder and a new one will save us. Can’t really say no more but I’m happy with what I was told as I had bought a few of these shares, hopefully what was spoken will come to fruition.
Wantthatone if this happens we will be good for the future.
Sharesforlife - lots of recommendations for your post, no doubt because we desperately all hope you’re right! But do tell us more……
Through various sources expect a RNS hopefully within 21 days. Dilution will happen but financing set to be announced then full steam ahead.
Regards
I predict that AVO will get through this
I did wonder why they refused to show their faces
When you say "the tea leaves" are you referring to the B.O.D?
I've been consulting the tea leaves and I think they will raise investment needed, find a keen buyer for the odey holding and cruise through first patient treatment. Relist the shares and sell at 80p. Who am I to argue with the tea leaves?
I wonder, would they keep the shares suspended even having raised some money? I’d have thought they would want to give investors the ability to trade in and out but what do I know? The market was rather disorderly before suspension, if that’s a consideration.
Also I doubt the company has had the money to prepare the treatment room and building, as that sounds like significant spend over and above the “keep the lights on” budget. I’d be amazed if first patient treatment doesn’t go back - that’s assuming they can keep going - but I’d live with anything that will keep the company going atm.
Revo unless they've tidy the place up at the testing facility in Cheshire patient treatment won't be happening. Be like asking someone to stand in the middle of building site and then firing a nail gun at them :)
I googled for how long a suspension can last. 6 Months is apparently the answer. If they can survive 6 months and get the first patient treatment, maybe triggering deposits for systems, would that be a route out of this mess? I don't be nelieve we need to wait for the Pebble mill centre to be built - surely they can put a patient in the chair in Warrington and zap them there? Not sure we even need a sterilised area due to the type of technology. Any one out there with proper knowhow? The directors can always sell their convertible loan notes, as those do not rely on trading to fulfil a contractual commitment, and that would keep some cash coming in and stop the price falling so far that the benefits to the owners of the loan notes becomes embarrassing.
Good question. Obviously, AVO is liable for the rent but if they haven't got the cash, perhaps no one is.
However, considering the many £millions that the Howard de Waldon Estate has spent on converting the buildings for AVO's use, they might be prepared to wait for their rent until AVO can afford to pay it.
I'm assuming that The Howard de Waldon Estate spent the money because they want AVO to succeed.
And who is paying the rent?
I'm baffled by the fact that on my shares account the AVO share price keeps changing. Anyone know why it's changing?
AVO have a 50 year lease on two adjoining houses in Harley Street. The two houses have been converted to adapt them for AVO's needs as a proton beam therapy treatment clinic. The conversions have been carried out by the landlords, the Howard de Walden Estate, at their own expense. The Howard de Walden Estate owns most , perhaps all, of Harley Street, together with a large chunk of Marylebone.
Didnt they have a building In Londons Harley Street where they were installing some machines to treat cancer patients?
I haven’t re-read Hardman’s reports but I think they only said the project had been “technically” de-risked? Which seems fair. Unfortunately we still have more than enough financial risk. And once we’ve got through that (hopefully) we can move on to tackle the regulatory risk, the manufacturing risk, the ....(etc. etc).
I'm a shareholder in AVO and I received a call from a money manager stating that if I was interested in AVO and their Tech, I should look at Positron Corp. (Symbol: POSC). Positron manufactures a PET medical device that is used to diagnose Cardiac disease. Positron is partners with Neusoft Medical a Chinese conglomerate in the manufacturing aspect . Positron is currently going through the FDA 510K process to manufacture and sell a PET-CT medical device.
GLTA
Hardman weren't independent. AVO paid them for their services. It meant that everything Hardman said was AVO's version of the facts.
There's nothing any of us can do about it, except wait and see what happens next. I've decided to remain hopeful until we're told that AVO has gone into administration.
Tell me about it talk about feeling duped however many of the senior directors threw a lot of money at this and really gave the impression they had belief in the technology. Follow the money was definitely not the right thing to have done. Nicholas Serandour was previously a financier I believe seems like he got something seriously wrong. So we have paid for a fully working maching in Daresbury and all they have to do is execute a verification plan that is well established with UHB and orders are awaiting......what a mess! If we still get something out of this it really will be a miracle!!
Remember all those notes from Hardman Research (e.g. 17 Jan 23) telling the whole project had been 'de-risked'?
Wonder what they're saying now?